Bone marrow mesenchymal stromal cells with CD47 high expression via the signal transducer and activators of transcription signaling pathway preventing myocardial fibrosis

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 9, 2015, Pages 10555-10564

  Deng, Wei ^a   Chen, Qing Wei ^a   Li, Xing Sheng ^a   Yuan, Zhong Ming ^a   Li, Gui Qiong ^a   Ke, Da Zhi ^a   Wang, Li ^a   Wu, Zhi Qing ^a   Luo, Shi Lan ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

CD47; Mesenchymal stromal cells; Myocardial fibrosis; Signal transducer and activators of transcription

Indexed keywords

BISPECIFIC ANTIBODY; CD47 ANTIGEN; CD47 PROTEIN, RAT; COLLAGEN; GELATINASE B; ISOPRENALINE; MMP9 PROTEIN, RAT; SRY PROTEIN, RAT; STAT1 PROTEIN; STAT1 PROTEIN, RAT; STAT3 PROTEIN; STAT3 PROTEIN, RAT; TESTIS DETERMINING FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE-1 PROTEIN, RAT; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL; CARDIAC MUSCLE; CARDIOMYOPATHIES; CELL CULTURE; CHEMICALLY INDUCED; DISEASE MODEL; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIBODIES, BISPECIFIC; ANTIGENS, CD47; CARDIOMYOPATHIES; CELLS, CULTURED; COLLAGEN; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; ISOPROTERENOL; MALE; MATRIX METALLOPROTEINASE 9; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIUM; PHENOTYPE; RATS, SPRAGUE-DAWLEY; SEX-DETERMINING REGION Y PROTEIN; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 85013127856     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. McNiece I. Stem cells for myocardial infarction. Cytotherapy 2015; 17: 243-244.
2. Yu J, Wu YK, Gu Y, Fang Q, Sievers R, Ding CH, Olgin JE and Lee RJ. Immuno-modifi cation of enhancing stem cells targeting for myocardial repair. J Cell Mol Med 2015; 19: 1483-91.
3. Fagan A, Asghar O, Pearce K, Stout M, Ray SG, Schmitt M and Malik RA. Medalists with extreme duration of type 1 diabetes exhibit only mild diastolic dysfunction and myocardial fi brosis. Diabetes Care 2015; 38: e5-6.
4. Thomas TO, Jefferies JL, Lorts A, Anderson JB, Gao Z, Benson DW, Hor KN, Cripe LH and Urbina EM. Autonomic dysfunction: a driving force for myocardial fi brosis in young Duchenne muscular dystrophy patients? Pediatr Cardiol 2015; 36: 561-568.
5. Lee SP, Lee W, Lee JM, Park EA, Kim HK, Kim YJ and Sohn DW. Assessment of diffuse myocardial fi brosis by using MR imaging in asymptomatic patients with aortic stenosis. Radiology 2015; 274: 359-369.
6. Rodriguez-Reyna TS, Morelos-Guzman M, He-Rnandez-Reyes P, Montero-Duarte K, Martinez-Reyes C, Reyes-Utrera C, Vazquez-La Madrid J, Morales-Blanhir J, Nunez-Alvarez C and Ca-Biedes-Contreras J. Assessment of myocardial fi brosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography. Rheumatology (Ox-ford) 2015; 54: 647-654.
7. Bruns H, Bessell C, Varela JC, Haupt C, Fang J, Pasemann S, Mackensen A, Oelke M, Schneck JP and Schutz C. CD47 Enhances In Vivo Functionality of Artifi cial Antigen-Presenting Cells. Clin Cancer Res 2015; 21: 2075-2083.
8. Xiao ZY, Banan B, Jia J, Manning PT, Hiebsch RR, Gunasekaran M, Upadhya GA, Frazier WA, Mohanakumar T, Lin Y and Chapman WC. CD47 blockade reduces ischemia/reperfusion injury and improves survival in a rat liver transplantation model. Liver Transpl 2015; 21: 468-477.
9. Zhang H, Li F, Yang Y, Chen J and Hu X. SIRP/CD47 signaling in neurological disorders. Brain Res 2015; 1623:74-80.
10. Soto-Pantoja DR, Kaur S and Roberts DD. CD47 signaling pathways controlling cellular differentiation and responses to stress. Crit Rev Biochem Mol Biol 2015; 1-19.
11. Warinrak C, Wu JT, Hsu WL, Liao JW, Chang SC and Cheng FP. Expression of matrix metalloproteinases (MMP-2, MMP-9) and their inhibitors (TIMP-1, TIMP-2) in canine testis, epididymis and semen. Reprod Domest Anim 2015; 50: 48-57.
12. Lorente L, Martin MM, Sole-Violan J, Blanquer J, Labarta L, Diaz C, Borreguero-Leon JM, Orbe J, Rodriguez JA, Jimenez A and Paramo JA. Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio. PLoS one 2014; 9: e94318.
13. Stine RR, Greenspan LJ, Ramachandran KV and Matunis EL. Coordinate regulation of stem cell competition by Slit-Robo and JAK-STAT signaling in the Drosophila testis. PLoS Genet 2014; 10: e1004713.
14. Maimon I, Popliker M and Gilboa L. Without children is required for Stat-mediated zfh1 transcription and for germline stem cell differentiation. Development 2014; 141: 2602-2610.
15. Chen HZ, Xia R, Guo YK, Hou JL, Zhang L-z, Li ZL, Ai H, Ning G and Gao FB. [Bone mesenchymal stem cell transplantation for acute myocardial infarction: in vivo tracing with multi-modality molecular imaging]. Sichuan Da Xue Xue Bao Yi Xue Ban 2014; 45: 898-902.
16. Chen H, Guo Y and Ning G. [Advances in treatment of myocardial infarction by mesenchymal stem cell transplantation]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2014; 31: 939-944.
17. Zhou Y, Wang S, Yu Z, Hoyt RF Jr, Hunt T, Kindzelski B, Shou D, Xie W, Du Y, Liu C and Horvath KA. Induced pluripotent stem cell transplantation in the treatment of porcine chronic myocardial ischemia. Ann Thorac Surg 2014; 98: 2130-2137.
18. Li X, Zhou J, Liu Z, Chen J, Lu S, Sun H, Li J, Lin Q, Yang B, Duan C, Xing MM and Wang C. A PNIPAAm-based thermosensitive hydrogel containing SWCNTs for stem cell transplantation in myocardial repair. Biomaterials 2014; 35: 5679-5688.
19. Yin Q, Pei Z, Wang H and Zhao Y. Cyclosporine A-nanoparticles enhance the therapeutic benefi t of adipose tissue-derived stem cell transplantation in a swine myocardial infarction model. Int J Nanomedicine 2014; 9: 17-26.
20. Rapoport N, Nam KH, Gupta R, Gao Z, Mohan P, Payne A, Todd N, Liu X, Kim T, Shea J, Scaife C, Parker DL, Jeong EK and Kennedy AM. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfl uorocarbon nanoemulsions. J Control Release 2011; 153: 4-15.
21. Evjen TJ, Nilssen EA, Barnert S, Schubert R, Brandl M and Fossheim SL. Ultrasound-mediated destabilization and drug release from liposomes comprising dioleoylphosphatidylethanolamine. Eur J Pharm Sci 2011; 42: 380-386.
22. Polat BE, Hart D, Langer R and Blankschtein D. Ultrasound-mediated transdermal drug delivery: mechanisms, scope, and emerging trends. J Control Release 2011; 152: 330-348.
23. Wang S, Raju BI, Leyvi E, Weinstein DA and Seip R. Acoustic accessibility investigation for ultrasound mediated treatment of glycogen storage disease type Ia patients. Ultrasound Med Biol 2011; 37: 1469-1477.
24. Wang CY, Yang CH, Lin YS, Chen CH and Huang KS. Anti-infl ammatory effect with high intensity focused ultrasound-mediated pulsatile deliv ery of diclofenac. Biomaterials 2012; 33: 1547-1553.
25. Deng W, Chen QW, Li XS, Liu H, Niu SQ, Zhou Y, Li GQ, Ke DZ and Mo XG. Bone marrow mesenchymal stromal cells with support of bispecifi c antibody and ultrasound-mediated microbubbles prevent myocardial fi brosis via the signal transducer and activators of transcription signaling pathway. Cytotherapy 2011; 13: 431-440.
26. Horio T and Kawano Y. [MMP/TIMP ratio and hypertensive target organ damage]. Nihon Rinsho 2006; 64 Suppl 6: 171-175.
27. Wu YG and Wang LX. [Function of MMP/TIMP on airway remodeling of bronchial asthma and treating effects of Zhichuan capsule]. Zhong Xi Yi Jie He Xue Bao 2004; 2: 435-439.
28. Stratmann B, Farr M and Tschesche H. MMP-TIMP interaction depends on residue 2 in TIMP-4. FEBS Lett 2001; 507: 285-287.
29. Maatta M, Soini Y, Liakka A and Autio-Harmainen H. Localization of MT1-MMP, TIMP-1, TIMP-2, and TIMP-3 messenger RNA in normal, hyperplastic, and neoplastic endometrium. Enhanced expression by endometrial adenocarcinomas is associated with low differentiation. Am J Clin Pathol 2000; 114: 402-411.
30. Li H, Simon H, Bocan TM and Peterson JT. MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE-and MMP-inhibition. Cardiovasc Res 2000; 46: 298-306.
31. Fortunato SJ, Menon R and Lombardi SJ. MMP/TIMP imbalance in amniotic fl uid during PROM: an indirect support for endogenous pathway to membrane rupture. J Perinat Med 1999; 27: 362-368.
32. Tsai CY, Chua S, Leu S, Chang AY, Chan JY and Chan SH. VEGF tonically sustains myocardial performance via fetal liver kinase-1 in the heart. Int J Cardiol 2014; 177: 727-730.
33. Moon HH, Joo MK, Mok H, Lee M, Hwang KC, Kim SW, Jeong JH, Choi D and Kim SH. MSC-based VEGF gene therapy in rat myocardial infarction model using facial amphipathic bile acid-conjugated polyethyleneimine. Biomater-ials 2014; 35: 1744-1754.